{"schema":"hottub-news/story/v1","story":"st_ld7swihtmgiemqmj4f6a","title":"Ainos Details Partner-Funded VELDONA Development and Revenue Opportunities, Reinforcing Focus on Chemical Intelligence","title_en":null,"outlets":5,"brief":null,"page":"https://hottub.news/stories/ainos-details-partner-funded-veldona-development-and-revenue-ld7swihtmg","count":5,"items":[{"id":"n_kkmqj4mwkmxjlrruda7q","seq":469679,"kind":"article","title":"Ainos Details Partner-Funded VELDONA Development and Revenue Opportunities, Reinforcing Focus on Chemical Intelligence","url":"http://www.tennesseedaily.com/news/279337626/ainos-details-partner-funded-veldona-development-and-revenue-opportunities-reinforcing-focus-on-chemical-intelligence","published":"2026-09-28T16:10:17Z","seen":"2026-09-28T16:10:17Z","lang":"en","source":{"id":"tennesseedaily.com","name":"tennesseedaily.com","domain":"tennesseedaily.com"},"via":"gdelt-gkg-english","topics":["economy","health","business","politics"],"entities":[{"id":"Q101828","name":"Ainu people","type":"org"}],"story":"st_ld7swihtmgiemqmj4f6a","category":"economy-business","category_p":0.6800000071525574,"category2":"science-technology","sentiment":"neutral","tone":0.3400000035762787,"political":0.03999999910593033},{"id":"n_upemyr7sijzowekynz4q","seq":448915,"kind":"article","title":"Ainos Details Partner-Funded VELDONA Development and Revenue Opportunities, Reinforcing Focus on Chemical Intelligence","url":"http://www.newjerseytelegraph.com/news/279337626/ainos-details-partner-funded-veldona-development-and-revenue-opportunities-reinforcing-focus-on-chemical-intelligence","published":"2026-09-28T14:23:24Z","seen":"2026-09-28T14:23:24Z","lang":"en","source":{"id":"newjerseytelegraph.com","name":"newjerseytelegraph.com","domain":"newjerseytelegraph.com"},"via":"gdelt-gkg-english","topics":["economy","business","health","politics"],"entities":[{"id":"Q101828","name":"Ainu people","type":"org"}],"story":"st_ld7swihtmgiemqmj4f6a","category":"economy-business","category_p":0.6800000071525574,"category2":"science-technology","sentiment":"neutral","tone":0.3400000035762787,"political":0.03999999910593033},{"id":"n_jdniz2sannp27qxm6p6q","seq":438370,"kind":"article","title":"Ainos Details Partner-Funded VELDONA Development and Revenue Opportunities, Reinforcing Focus on Chemical Intelligence","url":"http://www.hawaiitelegraph.com/news/279337626/ainos-details-partner-funded-veldona-development-and-revenue-opportunities-reinforcing-focus-on-chemical-intelligence","published":"2026-09-28T13:36:37Z","seen":"2026-09-28T13:36:37Z","lang":"en","source":{"id":"hawaiitelegraph.com","name":"hawaiitelegraph.com","domain":"hawaiitelegraph.com"},"via":"gdelt-gkg-english","topics":["economy","business","health","politics"],"entities":[{"id":"Q101828","name":"Ainu people","type":"org"}],"story":"st_ld7swihtmgiemqmj4f6a","category":"economy-business","category_p":0.6800000071525574,"category2":"science-technology","sentiment":"neutral","tone":0.3400000035762787,"political":0.03999999910593033},{"id":"n_dwjxn6xunkmkar5fu3jq","seq":426947,"kind":"article","title":"Ainos Details Partner-Funded VELDONA Development and Revenue Opportunities, ...","url":"https://www.pr-inside.com/ainos-details-partner-funded-veldona-development-and-revenue-opportunities-r5228060.htm","published":"2026-09-28T12:41:37Z","seen":"2026-09-28T12:41:37Z","lang":"en","source":{"id":"pr-inside.com","name":"pr-inside.com","domain":"pr-inside.com"},"via":"gdelt-gkg-english","topics":["economy","health","business"],"entities":[{"id":"Q101828","name":"Ainu people","type":"org"}],"story":"st_ld7swihtmgiemqmj4f6a","category":"economy-business","category_p":0.9100000262260437,"sentiment":"positive","tone":0.49000000953674316,"political":0.029999999329447746},{"id":"n_ld7swihtmgiemqmj4f6a","seq":420701,"kind":"press_release","title":"Ainos Details Partner-Funded VELDONA Development and Revenue Opportunities, Reinforcing Focus on Chemical Intelligence","url":"https://www.newswire.com/news/ainos-details-partner-funded-veldona-development-and-revenue-opportunities","summary":"Initial license payment tied to near-term contractual delivery; additional payment opportunities may arise during development, before drug approval Partner assumes assigned clinical and regulatory funding and execution, reducing Ainos' independent capital and staffing requirements Ainos retains existing platform ownership and 25% of applicable net sublicensing revenue; potential economic participation extends beyond the $10 million licensing framework","published":"2026-09-28T12:00:00Z","seen":"2026-09-28T12:15:23Z","lang":"en","source":{"id":"newswire-com","name":"Newswire.com","domain":"newswire.com","outlet":{"wikidata":"Q124976778","name":"Newswire","type":"news_agency","designations":["news agency"]}},"via":"newswire-com","topics":["business"],"entities":[{"id":"Q101828","name":"Ainu people","type":"org"}],"story":"st_ld7swihtmgiemqmj4f6a","category":"economy-business","category_p":0.6800000071525574,"category2":"science-technology","sentiment":"neutral","tone":0.38999998569488525,"political":0.03999999910593033}]}